EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy

Michael LaPelusa iD, Preksha Shah, Deepak Bhamidipati, Naishu Kui, Alisha Bent, Arvind Dasari iD, Ryan Huey, Bryan Kee iD, Scott Kopetz iD, Phat Le, Kaysia Ludford, Maria Pia Morelli und 8 weitere

The Oncologist · 2026

DOI: 10.1093/oncolo/oyag235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Michael LaPelusa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX 77030, United States. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Microsatellite Instability, Immunotherapy, DNA Mismatch Repair. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunotherapy has shown to be efficacious in patients with deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer (CRC). Unfortunately, there is still a population of patients who either do not respond or progress after prior response. Understanding the progression dynamics and outcomes based on the nature of disease progression (PD) is critical in this patient population.

Methods

We performed a retrospective analysis of 166 patients with advanced dMMR/MSI-H CRC who received immunotherapy. PD patterns were classified as intrinsic (progression at first restaging scan) or adaptive (progression after initial stable/responding disease) and as single organ or systemic.

Results

Progression was seen in 64 patients (38.6%) with single organ progression in 31 (48.4%) and systemic progression in 33 (51.5%). Intrinsic progression was seen in 32 patients (50%) and adaptive progression in 32 (50%). Patients with single organ progression had a longer median TTP (mTTP) and median OS (mOS) compared to patients with systemic progression (mTTP: 8.8 vs 4.0 months, P = .005; mOS: 65.9 vs 18.7 months, P = .023). Patients with adaptive PD had a longer mTTP and mOS compared to patients with intrinsic PD (mTTP: 11.6 vs 1.9 months, P = <.01; mOS: 65.9 months vs 17.0 months, P = .001).

Conclusion

This analysis identifies significant differences in outcomes of patients with dMMR/MSI-H CRC based on the pattern and extent of progression, underscoring the need for tailored therapeutic strategies depending on the nature of PD-1-based progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicrosatellite InstabilityImmunotherapyDNA Mismatch RepairHumansFemaleMaleDisease ProgressionAgedMiddle AgedRetrospective StudiesAdultAged, 80 and overNeoplasm Metastasis

Stichwörter der Autor:innen

MSI-H/dMMRcolorectal cancerimmune checkpoint blockadeimmunotherapy

Autor:innen und Institutionen

  • Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Sarah Cannon Research Institute, Nashville, TN 37203, United States.
  • Department of Biostatistics, MD Anderson Cancer Center, Houston, TX 77030, United States.

ORCID-Profile: Michael LaPelusa, Arvind Dasari, Bryan Kee, Scott Kopetz, Van K Morris, Christine Parseghian, Jason Willis, Robert Wolff, Dan Zhao, Victoria S Higbie

Zitieren

APA

LaPelusa, M., Shah, P., Bhamidipati, D., Kui, N., Bent, A., Dasari, A., Huey, R., Kee, B., Kopetz, S., Le, P., Ludford, K., Morelli, M. P., Morris, V. K., Parseghian, C., Raghav, K., Willis, J., Wolff, R., Zhao, D., Overman, M. J., & Higbie, V. S. (2026). Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy. The Oncologist. https://doi.org/10.1093/oncolo/oyag235

Vancouver

LaPelusa M, Shah P, Bhamidipati D, Kui N, Bent A, Dasari A, et al. Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy. The Oncologist. 2026. doi:10.1093/oncolo/oyag235

BibTeX
@article{LaPelusa2026,
  author = {LaPelusa, Michael and Shah, Preksha and Bhamidipati, Deepak and Kui, Naishu and Bent, Alisha and Dasari, Arvind and Huey, Ryan and Kee, Bryan and Kopetz, Scott and Le, Phat and Ludford, Kaysia and Morelli, Maria Pia and Morris, Van K and Parseghian, Christine and Raghav, Kanwal and Willis, Jason and Wolff, Robert and Zhao, Dan and Overman, Michael J and Higbie, Victoria S},
  title = {Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy},
  journal = {The Oncologist},
  year = {2026},
  doi = {10.1093/oncolo/oyag235}
}
Kostenlos starten →